Sofie Jacobs
Global Public Health R&D
Beerse, VLG, Belgium
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Optimal preclinical models for human dose projection of SARS-CoV-2 small molecule direct-acting antivirals.
Journal: Antiviral research
Published: September 03, 2025
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.
Journal: Nature
Published: February 21, 2024
Perturbation of Alphavirus and Flavivirus Infectivity by Components of the Bacterial Cell Wall.
Journal: Journal of virology
Published: February 02, 2022
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.
Journal: Science translational medicine
Published: October 05, 2021
Posaconazole inhibits multiple steps of the alphavirus replication cycle.
Journal: Antiviral research
Published: September 02, 2021
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial.
Journal: EBioMedicine
Published: November 25, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 10, 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.
Journal: Nature communications
Published: September 18, 2020
Last Updated: 09/26/2026